nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—ABCC2—Sorafenib—thyroid cancer	0.292	0.469	CbGbCtD
Levetiracetam—ABCC2—Doxorubicin—thyroid cancer	0.177	0.285	CbGbCtD
Levetiracetam—ABCB1—Sorafenib—thyroid cancer	0.0953	0.153	CbGbCtD
Levetiracetam—ABCB1—Doxorubicin—thyroid cancer	0.0578	0.0928	CbGbCtD
Levetiracetam—Blood disorder—Doxorubicin—thyroid cancer	0.0012	0.00317	CcSEcCtD
Levetiracetam—Viral infection—Epirubicin—thyroid cancer	0.0012	0.00317	CcSEcCtD
Levetiracetam—Skin discolouration—Epirubicin—thyroid cancer	0.0012	0.00317	CcSEcCtD
Levetiracetam—Thinking abnormal—Epirubicin—thyroid cancer	0.00118	0.00313	CcSEcCtD
Levetiracetam—Cough increased—Epirubicin—thyroid cancer	0.00118	0.00313	CcSEcCtD
Levetiracetam—Dyskinesia—Epirubicin—thyroid cancer	0.00115	0.00305	CcSEcCtD
Levetiracetam—Leukopenia—Sorafenib—thyroid cancer	0.00114	0.00303	CcSEcCtD
Levetiracetam—Cough—Sorafenib—thyroid cancer	0.00111	0.00296	CcSEcCtD
Levetiracetam—Asthenia—Vandetanib—thyroid cancer	0.00111	0.00294	CcSEcCtD
Levetiracetam—Gait disturbance—Epirubicin—thyroid cancer	0.00111	0.00293	CcSEcCtD
Levetiracetam—Viral infection—Doxorubicin—thyroid cancer	0.00111	0.00293	CcSEcCtD
Levetiracetam—Skin discolouration—Doxorubicin—thyroid cancer	0.00111	0.00293	CcSEcCtD
Levetiracetam—Coordination abnormal—Epirubicin—thyroid cancer	0.0011	0.00292	CcSEcCtD
Levetiracetam—Pruritus—Vandetanib—thyroid cancer	0.00109	0.0029	CcSEcCtD
Levetiracetam—Neck pain—Epirubicin—thyroid cancer	0.00109	0.0029	CcSEcCtD
Levetiracetam—Thinking abnormal—Doxorubicin—thyroid cancer	0.00109	0.00289	CcSEcCtD
Levetiracetam—Cough increased—Doxorubicin—thyroid cancer	0.00109	0.00289	CcSEcCtD
Levetiracetam—Myalgia—Sorafenib—thyroid cancer	0.00109	0.00288	CcSEcCtD
Levetiracetam—Arthralgia—Sorafenib—thyroid cancer	0.00109	0.00288	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00108	0.00286	CcSEcCtD
Levetiracetam—Hepatocellular injury—Epirubicin—thyroid cancer	0.00108	0.00286	CcSEcCtD
Levetiracetam—Dyskinesia—Doxorubicin—thyroid cancer	0.00106	0.00282	CcSEcCtD
Levetiracetam—Diarrhoea—Vandetanib—thyroid cancer	0.00106	0.0028	CcSEcCtD
Levetiracetam—Infection—Sorafenib—thyroid cancer	0.00104	0.00275	CcSEcCtD
Levetiracetam—Gait disturbance—Doxorubicin—thyroid cancer	0.00102	0.00271	CcSEcCtD
Levetiracetam—Nervous system disorder—Sorafenib—thyroid cancer	0.00102	0.00271	CcSEcCtD
Levetiracetam—Dizziness—Vandetanib—thyroid cancer	0.00102	0.00271	CcSEcCtD
Levetiracetam—Thrombocytopenia—Sorafenib—thyroid cancer	0.00102	0.00271	CcSEcCtD
Levetiracetam—Coordination abnormal—Doxorubicin—thyroid cancer	0.00102	0.0027	CcSEcCtD
Levetiracetam—Skin disorder—Sorafenib—thyroid cancer	0.00101	0.00269	CcSEcCtD
Levetiracetam—Neck pain—Doxorubicin—thyroid cancer	0.00101	0.00268	CcSEcCtD
Levetiracetam—Hepatocellular injury—Doxorubicin—thyroid cancer	0.000999	0.00265	CcSEcCtD
Levetiracetam—Anorexia—Sorafenib—thyroid cancer	0.000993	0.00264	CcSEcCtD
Levetiracetam—Vomiting—Vandetanib—thyroid cancer	0.000982	0.00261	CcSEcCtD
Levetiracetam—Mouth ulceration—Epirubicin—thyroid cancer	0.000976	0.00259	CcSEcCtD
Levetiracetam—Ecchymosis—Epirubicin—thyroid cancer	0.000976	0.00259	CcSEcCtD
Levetiracetam—Rash—Vandetanib—thyroid cancer	0.000974	0.00258	CcSEcCtD
Levetiracetam—Dermatitis—Vandetanib—thyroid cancer	0.000973	0.00258	CcSEcCtD
Levetiracetam—Headache—Vandetanib—thyroid cancer	0.000968	0.00257	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000949	0.00252	CcSEcCtD
Levetiracetam—Mental disability—Epirubicin—thyroid cancer	0.000937	0.00248	CcSEcCtD
Levetiracetam—Nausea—Vandetanib—thyroid cancer	0.000918	0.00243	CcSEcCtD
Levetiracetam—Dyspepsia—Sorafenib—thyroid cancer	0.000917	0.00243	CcSEcCtD
Levetiracetam—Decreased appetite—Sorafenib—thyroid cancer	0.000906	0.0024	CcSEcCtD
Levetiracetam—Mouth ulceration—Doxorubicin—thyroid cancer	0.000903	0.0024	CcSEcCtD
Levetiracetam—Ecchymosis—Doxorubicin—thyroid cancer	0.000903	0.0024	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.0009	0.00239	CcSEcCtD
Levetiracetam—Fatigue—Sorafenib—thyroid cancer	0.000898	0.00238	CcSEcCtD
Levetiracetam—Constipation—Sorafenib—thyroid cancer	0.000891	0.00236	CcSEcCtD
Levetiracetam—Pain—Sorafenib—thyroid cancer	0.000891	0.00236	CcSEcCtD
Levetiracetam—Eczema—Epirubicin—thyroid cancer	0.000872	0.00231	CcSEcCtD
Levetiracetam—Hepatic failure—Epirubicin—thyroid cancer	0.000872	0.00231	CcSEcCtD
Levetiracetam—Mental disability—Doxorubicin—thyroid cancer	0.000867	0.0023	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000852	0.00226	CcSEcCtD
Levetiracetam—Abdominal pain—Sorafenib—thyroid cancer	0.000824	0.00219	CcSEcCtD
Levetiracetam—Body temperature increased—Sorafenib—thyroid cancer	0.000824	0.00219	CcSEcCtD
Levetiracetam—Renal impairment—Epirubicin—thyroid cancer	0.000823	0.00218	CcSEcCtD
Levetiracetam—Dermatitis bullous—Epirubicin—thyroid cancer	0.00082	0.00217	CcSEcCtD
Levetiracetam—Hepatic failure—Doxorubicin—thyroid cancer	0.000807	0.00214	CcSEcCtD
Levetiracetam—Eczema—Doxorubicin—thyroid cancer	0.000807	0.00214	CcSEcCtD
Levetiracetam—Lethargy—Epirubicin—thyroid cancer	0.0008	0.00212	CcSEcCtD
Levetiracetam—Hyponatraemia—Epirubicin—thyroid cancer	0.000787	0.00209	CcSEcCtD
Levetiracetam—Diplopia—Epirubicin—thyroid cancer	0.000784	0.00208	CcSEcCtD
Levetiracetam—Affect lability—Epirubicin—thyroid cancer	0.000771	0.00205	CcSEcCtD
Levetiracetam—Hypersensitivity—Sorafenib—thyroid cancer	0.000768	0.00204	CcSEcCtD
Levetiracetam—Renal impairment—Doxorubicin—thyroid cancer	0.000762	0.00202	CcSEcCtD
Levetiracetam—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000759	0.00201	CcSEcCtD
Levetiracetam—Face oedema—Epirubicin—thyroid cancer	0.000756	0.00201	CcSEcCtD
Levetiracetam—Asthenia—Sorafenib—thyroid cancer	0.000748	0.00198	CcSEcCtD
Levetiracetam—Mood swings—Epirubicin—thyroid cancer	0.000742	0.00197	CcSEcCtD
Levetiracetam—Lethargy—Doxorubicin—thyroid cancer	0.00074	0.00196	CcSEcCtD
Levetiracetam—Pruritus—Sorafenib—thyroid cancer	0.000737	0.00196	CcSEcCtD
Levetiracetam—Ataxia—Epirubicin—thyroid cancer	0.000737	0.00195	CcSEcCtD
Levetiracetam—Dehydration—Epirubicin—thyroid cancer	0.000729	0.00193	CcSEcCtD
Levetiracetam—Hyponatraemia—Doxorubicin—thyroid cancer	0.000728	0.00193	CcSEcCtD
Levetiracetam—Diplopia—Doxorubicin—thyroid cancer	0.000725	0.00192	CcSEcCtD
Levetiracetam—Liver function test abnormal—Epirubicin—thyroid cancer	0.000723	0.00192	CcSEcCtD
Levetiracetam—Abdominal pain upper—Epirubicin—thyroid cancer	0.000716	0.0019	CcSEcCtD
Levetiracetam—Affect lability—Doxorubicin—thyroid cancer	0.000714	0.00189	CcSEcCtD
Levetiracetam—Diarrhoea—Sorafenib—thyroid cancer	0.000713	0.00189	CcSEcCtD
Levetiracetam—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000706	0.00187	CcSEcCtD
Levetiracetam—Nasopharyngitis—Epirubicin—thyroid cancer	0.000701	0.00186	CcSEcCtD
Levetiracetam—Face oedema—Doxorubicin—thyroid cancer	0.0007	0.00186	CcSEcCtD
Levetiracetam—Muscular weakness—Epirubicin—thyroid cancer	0.000691	0.00183	CcSEcCtD
Levetiracetam—Dizziness—Sorafenib—thyroid cancer	0.000689	0.00183	CcSEcCtD
Levetiracetam—Mood swings—Doxorubicin—thyroid cancer	0.000687	0.00182	CcSEcCtD
Levetiracetam—Ataxia—Doxorubicin—thyroid cancer	0.000682	0.00181	CcSEcCtD
Levetiracetam—Asthma—Epirubicin—thyroid cancer	0.000677	0.0018	CcSEcCtD
Levetiracetam—Influenza—Epirubicin—thyroid cancer	0.000677	0.0018	CcSEcCtD
Levetiracetam—Dehydration—Doxorubicin—thyroid cancer	0.000674	0.00179	CcSEcCtD
Levetiracetam—Eosinophilia—Epirubicin—thyroid cancer	0.000671	0.00178	CcSEcCtD
Levetiracetam—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000669	0.00178	CcSEcCtD
Levetiracetam—Pancreatitis—Epirubicin—thyroid cancer	0.000664	0.00176	CcSEcCtD
Levetiracetam—Vomiting—Sorafenib—thyroid cancer	0.000663	0.00176	CcSEcCtD
Levetiracetam—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000662	0.00176	CcSEcCtD
Levetiracetam—Rash—Sorafenib—thyroid cancer	0.000657	0.00174	CcSEcCtD
Levetiracetam—Dermatitis—Sorafenib—thyroid cancer	0.000656	0.00174	CcSEcCtD
Levetiracetam—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000653	0.00173	CcSEcCtD
Levetiracetam—Headache—Sorafenib—thyroid cancer	0.000653	0.00173	CcSEcCtD
Levetiracetam—Bronchitis—Epirubicin—thyroid cancer	0.000651	0.00173	CcSEcCtD
Levetiracetam—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000648	0.00172	CcSEcCtD
Levetiracetam—Pancytopenia—Epirubicin—thyroid cancer	0.000643	0.00171	CcSEcCtD
Levetiracetam—Muscular weakness—Doxorubicin—thyroid cancer	0.000639	0.0017	CcSEcCtD
Levetiracetam—Neutropenia—Epirubicin—thyroid cancer	0.000633	0.00168	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000629	0.00167	CcSEcCtD
Levetiracetam—Asthma—Doxorubicin—thyroid cancer	0.000627	0.00166	CcSEcCtD
Levetiracetam—Influenza—Doxorubicin—thyroid cancer	0.000627	0.00166	CcSEcCtD
Levetiracetam—Eosinophilia—Doxorubicin—thyroid cancer	0.00062	0.00165	CcSEcCtD
Levetiracetam—Nausea—Sorafenib—thyroid cancer	0.000619	0.00164	CcSEcCtD
Levetiracetam—Weight increased—Epirubicin—thyroid cancer	0.000616	0.00163	CcSEcCtD
Levetiracetam—Pancreatitis—Doxorubicin—thyroid cancer	0.000614	0.00163	CcSEcCtD
Levetiracetam—Weight decreased—Epirubicin—thyroid cancer	0.000613	0.00163	CcSEcCtD
Levetiracetam—Infestation NOS—Epirubicin—thyroid cancer	0.000604	0.0016	CcSEcCtD
Levetiracetam—Infestation—Epirubicin—thyroid cancer	0.000604	0.0016	CcSEcCtD
Levetiracetam—Drowsiness—Epirubicin—thyroid cancer	0.000604	0.0016	CcSEcCtD
Levetiracetam—Bronchitis—Doxorubicin—thyroid cancer	0.000603	0.0016	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000599	0.00159	CcSEcCtD
Levetiracetam—Pancytopenia—Doxorubicin—thyroid cancer	0.000595	0.00158	CcSEcCtD
Levetiracetam—Stomatitis—Epirubicin—thyroid cancer	0.000589	0.00156	CcSEcCtD
Levetiracetam—Urinary tract infection—Epirubicin—thyroid cancer	0.000587	0.00156	CcSEcCtD
Levetiracetam—Conjunctivitis—Epirubicin—thyroid cancer	0.000587	0.00156	CcSEcCtD
Levetiracetam—Neutropenia—Doxorubicin—thyroid cancer	0.000586	0.00155	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000582	0.00154	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000571	0.00151	CcSEcCtD
Levetiracetam—Weight increased—Doxorubicin—thyroid cancer	0.00057	0.00151	CcSEcCtD
Levetiracetam—Epistaxis—Epirubicin—thyroid cancer	0.00057	0.00151	CcSEcCtD
Levetiracetam—Weight decreased—Doxorubicin—thyroid cancer	0.000567	0.0015	CcSEcCtD
Levetiracetam—Sinusitis—Epirubicin—thyroid cancer	0.000567	0.0015	CcSEcCtD
Levetiracetam—Agranulocytosis—Epirubicin—thyroid cancer	0.000564	0.00149	CcSEcCtD
Levetiracetam—Infestation NOS—Doxorubicin—thyroid cancer	0.000559	0.00148	CcSEcCtD
Levetiracetam—Infestation—Doxorubicin—thyroid cancer	0.000559	0.00148	CcSEcCtD
Levetiracetam—Drowsiness—Doxorubicin—thyroid cancer	0.000559	0.00148	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000554	0.00147	CcSEcCtD
Levetiracetam—Stomatitis—Doxorubicin—thyroid cancer	0.000545	0.00144	CcSEcCtD
Levetiracetam—Rhinitis—Epirubicin—thyroid cancer	0.000543	0.00144	CcSEcCtD
Levetiracetam—Conjunctivitis—Doxorubicin—thyroid cancer	0.000543	0.00144	CcSEcCtD
Levetiracetam—Urinary tract infection—Doxorubicin—thyroid cancer	0.000543	0.00144	CcSEcCtD
Levetiracetam—Hepatitis—Epirubicin—thyroid cancer	0.000542	0.00144	CcSEcCtD
Levetiracetam—Pharyngitis—Epirubicin—thyroid cancer	0.000538	0.00143	CcSEcCtD
Levetiracetam—Connective tissue disorder—Epirubicin—thyroid cancer	0.000533	0.00141	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000528	0.0014	CcSEcCtD
Levetiracetam—Epistaxis—Doxorubicin—thyroid cancer	0.000527	0.0014	CcSEcCtD
Levetiracetam—Sinusitis—Doxorubicin—thyroid cancer	0.000524	0.00139	CcSEcCtD
Levetiracetam—Agranulocytosis—Doxorubicin—thyroid cancer	0.000521	0.00138	CcSEcCtD
Levetiracetam—Erythema multiforme—Epirubicin—thyroid cancer	0.000513	0.00136	CcSEcCtD
Levetiracetam—Eye disorder—Epirubicin—thyroid cancer	0.000507	0.00134	CcSEcCtD
Levetiracetam—Rhinitis—Doxorubicin—thyroid cancer	0.000503	0.00133	CcSEcCtD
Levetiracetam—Hepatitis—Doxorubicin—thyroid cancer	0.000502	0.00133	CcSEcCtD
Levetiracetam—Pharyngitis—Doxorubicin—thyroid cancer	0.000498	0.00132	CcSEcCtD
Levetiracetam—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000493	0.00131	CcSEcCtD
Levetiracetam—Immune system disorder—Epirubicin—thyroid cancer	0.00049	0.0013	CcSEcCtD
Levetiracetam—Mediastinal disorder—Epirubicin—thyroid cancer	0.000489	0.0013	CcSEcCtD
Levetiracetam—Alopecia—Epirubicin—thyroid cancer	0.000479	0.00127	CcSEcCtD
Levetiracetam—Mental disorder—Epirubicin—thyroid cancer	0.000475	0.00126	CcSEcCtD
Levetiracetam—Erythema multiforme—Doxorubicin—thyroid cancer	0.000474	0.00126	CcSEcCtD
Levetiracetam—Malnutrition—Epirubicin—thyroid cancer	0.000472	0.00125	CcSEcCtD
Levetiracetam—Eye disorder—Doxorubicin—thyroid cancer	0.000469	0.00124	CcSEcCtD
Levetiracetam—Tension—Epirubicin—thyroid cancer	0.000463	0.00123	CcSEcCtD
Levetiracetam—Nervousness—Epirubicin—thyroid cancer	0.000458	0.00122	CcSEcCtD
Levetiracetam—Back pain—Epirubicin—thyroid cancer	0.000456	0.00121	CcSEcCtD
Levetiracetam—Immune system disorder—Doxorubicin—thyroid cancer	0.000453	0.0012	CcSEcCtD
Levetiracetam—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000452	0.0012	CcSEcCtD
Levetiracetam—Vision blurred—Epirubicin—thyroid cancer	0.000445	0.00118	CcSEcCtD
Levetiracetam—Alopecia—Doxorubicin—thyroid cancer	0.000443	0.00118	CcSEcCtD
Levetiracetam—Mental disorder—Doxorubicin—thyroid cancer	0.000439	0.00117	CcSEcCtD
Levetiracetam—Malnutrition—Doxorubicin—thyroid cancer	0.000437	0.00116	CcSEcCtD
Levetiracetam—Agitation—Epirubicin—thyroid cancer	0.000434	0.00115	CcSEcCtD
Levetiracetam—Tension—Doxorubicin—thyroid cancer	0.000428	0.00114	CcSEcCtD
Levetiracetam—Nervousness—Doxorubicin—thyroid cancer	0.000424	0.00112	CcSEcCtD
Levetiracetam—Vertigo—Epirubicin—thyroid cancer	0.000424	0.00112	CcSEcCtD
Levetiracetam—Leukopenia—Epirubicin—thyroid cancer	0.000422	0.00112	CcSEcCtD
Levetiracetam—Back pain—Doxorubicin—thyroid cancer	0.000422	0.00112	CcSEcCtD
Levetiracetam—Cough—Epirubicin—thyroid cancer	0.000412	0.00109	CcSEcCtD
Levetiracetam—Vision blurred—Doxorubicin—thyroid cancer	0.000411	0.00109	CcSEcCtD
Levetiracetam—Convulsion—Epirubicin—thyroid cancer	0.000409	0.00108	CcSEcCtD
Levetiracetam—Arthralgia—Epirubicin—thyroid cancer	0.000402	0.00107	CcSEcCtD
Levetiracetam—Chest pain—Epirubicin—thyroid cancer	0.000402	0.00107	CcSEcCtD
Levetiracetam—Myalgia—Epirubicin—thyroid cancer	0.000402	0.00107	CcSEcCtD
Levetiracetam—Agitation—Doxorubicin—thyroid cancer	0.000401	0.00106	CcSEcCtD
Levetiracetam—Anxiety—Epirubicin—thyroid cancer	0.0004	0.00106	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000399	0.00106	CcSEcCtD
Levetiracetam—Vertigo—Doxorubicin—thyroid cancer	0.000392	0.00104	CcSEcCtD
Levetiracetam—Leukopenia—Doxorubicin—thyroid cancer	0.000391	0.00104	CcSEcCtD
Levetiracetam—Confusional state—Epirubicin—thyroid cancer	0.000388	0.00103	CcSEcCtD
Levetiracetam—Infection—Epirubicin—thyroid cancer	0.000383	0.00101	CcSEcCtD
Levetiracetam—Cough—Doxorubicin—thyroid cancer	0.000381	0.00101	CcSEcCtD
Levetiracetam—Convulsion—Doxorubicin—thyroid cancer	0.000378	0.001	CcSEcCtD
Levetiracetam—Nervous system disorder—Epirubicin—thyroid cancer	0.000378	0.001	CcSEcCtD
Levetiracetam—Thrombocytopenia—Epirubicin—thyroid cancer	0.000377	0.001	CcSEcCtD
Levetiracetam—Skin disorder—Epirubicin—thyroid cancer	0.000374	0.000992	CcSEcCtD
Levetiracetam—Arthralgia—Doxorubicin—thyroid cancer	0.000372	0.000986	CcSEcCtD
Levetiracetam—Chest pain—Doxorubicin—thyroid cancer	0.000372	0.000986	CcSEcCtD
Levetiracetam—Myalgia—Doxorubicin—thyroid cancer	0.000372	0.000986	CcSEcCtD
Levetiracetam—Anxiety—Doxorubicin—thyroid cancer	0.00037	0.000983	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000369	0.000979	CcSEcCtD
Levetiracetam—Anorexia—Epirubicin—thyroid cancer	0.000367	0.000974	CcSEcCtD
Levetiracetam—Confusional state—Doxorubicin—thyroid cancer	0.000359	0.000953	CcSEcCtD
Levetiracetam—Infection—Doxorubicin—thyroid cancer	0.000354	0.000939	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000351	0.000931	CcSEcCtD
Levetiracetam—Nervous system disorder—Doxorubicin—thyroid cancer	0.000349	0.000927	CcSEcCtD
Levetiracetam—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000349	0.000926	CcSEcCtD
Levetiracetam—Insomnia—Epirubicin—thyroid cancer	0.000348	0.000924	CcSEcCtD
Levetiracetam—Skin disorder—Doxorubicin—thyroid cancer	0.000346	0.000918	CcSEcCtD
Levetiracetam—Paraesthesia—Epirubicin—thyroid cancer	0.000346	0.000917	CcSEcCtD
Levetiracetam—Somnolence—Epirubicin—thyroid cancer	0.000342	0.000908	CcSEcCtD
Levetiracetam—Anorexia—Doxorubicin—thyroid cancer	0.00034	0.000901	CcSEcCtD
Levetiracetam—Dyspepsia—Epirubicin—thyroid cancer	0.000339	0.000899	CcSEcCtD
Levetiracetam—Decreased appetite—Epirubicin—thyroid cancer	0.000335	0.000888	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000332	0.000882	CcSEcCtD
Levetiracetam—Fatigue—Epirubicin—thyroid cancer	0.000332	0.000881	CcSEcCtD
Levetiracetam—Pain—Epirubicin—thyroid cancer	0.000329	0.000874	CcSEcCtD
Levetiracetam—Constipation—Epirubicin—thyroid cancer	0.000329	0.000874	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000325	0.000861	CcSEcCtD
Levetiracetam—Insomnia—Doxorubicin—thyroid cancer	0.000322	0.000855	CcSEcCtD
Levetiracetam—Paraesthesia—Doxorubicin—thyroid cancer	0.00032	0.000849	CcSEcCtD
Levetiracetam—Feeling abnormal—Epirubicin—thyroid cancer	0.000317	0.000842	CcSEcCtD
Levetiracetam—Somnolence—Doxorubicin—thyroid cancer	0.000317	0.00084	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000315	0.000835	CcSEcCtD
Levetiracetam—Dyspepsia—Doxorubicin—thyroid cancer	0.000314	0.000832	CcSEcCtD
Levetiracetam—Decreased appetite—Doxorubicin—thyroid cancer	0.00031	0.000822	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000308	0.000816	CcSEcCtD
Levetiracetam—Fatigue—Doxorubicin—thyroid cancer	0.000307	0.000815	CcSEcCtD
Levetiracetam—Pain—Doxorubicin—thyroid cancer	0.000305	0.000808	CcSEcCtD
Levetiracetam—Constipation—Doxorubicin—thyroid cancer	0.000305	0.000808	CcSEcCtD
Levetiracetam—Body temperature increased—Epirubicin—thyroid cancer	0.000304	0.000808	CcSEcCtD
Levetiracetam—Abdominal pain—Epirubicin—thyroid cancer	0.000304	0.000808	CcSEcCtD
Levetiracetam—Feeling abnormal—Doxorubicin—thyroid cancer	0.000294	0.000779	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000291	0.000773	CcSEcCtD
Levetiracetam—Hypersensitivity—Epirubicin—thyroid cancer	0.000284	0.000753	CcSEcCtD
Levetiracetam—Abdominal pain—Doxorubicin—thyroid cancer	0.000282	0.000747	CcSEcCtD
Levetiracetam—Body temperature increased—Doxorubicin—thyroid cancer	0.000282	0.000747	CcSEcCtD
Levetiracetam—Asthenia—Epirubicin—thyroid cancer	0.000276	0.000733	CcSEcCtD
Levetiracetam—Pruritus—Epirubicin—thyroid cancer	0.000272	0.000723	CcSEcCtD
Levetiracetam—Diarrhoea—Epirubicin—thyroid cancer	0.000264	0.000699	CcSEcCtD
Levetiracetam—Hypersensitivity—Doxorubicin—thyroid cancer	0.000263	0.000696	CcSEcCtD
Levetiracetam—Asthenia—Doxorubicin—thyroid cancer	0.000256	0.000678	CcSEcCtD
Levetiracetam—Dizziness—Epirubicin—thyroid cancer	0.000255	0.000676	CcSEcCtD
Levetiracetam—Pruritus—Doxorubicin—thyroid cancer	0.000252	0.000669	CcSEcCtD
Levetiracetam—Vomiting—Epirubicin—thyroid cancer	0.000245	0.00065	CcSEcCtD
Levetiracetam—Diarrhoea—Doxorubicin—thyroid cancer	0.000244	0.000647	CcSEcCtD
Levetiracetam—Rash—Epirubicin—thyroid cancer	0.000243	0.000644	CcSEcCtD
Levetiracetam—Dermatitis—Epirubicin—thyroid cancer	0.000243	0.000644	CcSEcCtD
Levetiracetam—Headache—Epirubicin—thyroid cancer	0.000241	0.00064	CcSEcCtD
Levetiracetam—Dizziness—Doxorubicin—thyroid cancer	0.000236	0.000625	CcSEcCtD
Levetiracetam—Nausea—Epirubicin—thyroid cancer	0.000229	0.000607	CcSEcCtD
Levetiracetam—Vomiting—Doxorubicin—thyroid cancer	0.000227	0.000601	CcSEcCtD
Levetiracetam—Rash—Doxorubicin—thyroid cancer	0.000225	0.000596	CcSEcCtD
Levetiracetam—Dermatitis—Doxorubicin—thyroid cancer	0.000224	0.000595	CcSEcCtD
Levetiracetam—Headache—Doxorubicin—thyroid cancer	0.000223	0.000592	CcSEcCtD
Levetiracetam—Nausea—Doxorubicin—thyroid cancer	0.000212	0.000561	CcSEcCtD
